Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
2.290
-0.050 (-2.14%)
Jun 30, 2025, 10:08 AM - Market open
Ventyx Biosciences Stock Forecast
Stock Price Forecast
The 4 analysts that cover Ventyx Biosciences stock have a consensus rating of "Buy" and an average price target of $11.33, which forecasts a 394.76% increase in the stock price over the next year. The lowest target is $9 and the highest is $14.
Price Target: $11.33 (+394.76%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 8, 2024.
Analyst Ratings
The average analyst rating for Ventyx Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | +162.01% | Nov 11, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | +293.01% | Nov 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | +162.01% | Oct 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | +162.01% | Sep 23, 2024 |
Financial Forecast
Revenue This Year
n/a
from 260.71M
Revenue Next Year
n/a
EPS This Year
-1.89
from -1.97
EPS Next Year
-2.01
from -1.89
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 2.7M | ||
Avg | n/a | n/a | 663,000 | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.67 | -1.71 | -1.62 | ||
Avg | -1.89 | -2.01 | -1.95 | ||
Low | -2.05 | -2.21 | -2.27 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.